Nyxoah Q4 2023 Earnings Report $10.50 +0.12 (+1.16%) As of 01/30/2025 03:59 PM Eastern Earnings HistoryForecast Nyxoah EPS ResultsActual EPS-$0.41Consensus EPS -$0.41Beat/MissMet ExpectationsOne Year Ago EPSN/ANyxoah Revenue ResultsActual Revenue$1.96 millionExpected Revenue$2.01 millionBeat/MissMissed by -$50.00 thousandYoY Revenue GrowthN/ANyxoah Announcement DetailsQuarterQ4 2023Date3/5/2024TimeN/AConference Call ResourcesConference CallConference Call TranscriptPress ReleaseNYXH Earnings HistoryConference Call AudioYour browser does not support the audio element. Listen Now.Powered by Nyxoah Earnings HeadlinesContrasting LeMaitre Vascular (NASDAQ:LMAT) and Nyxoah (NASDAQ:NYXH)January 24, 2025 | americanbankingnews.comPublication relating to transparency notificationsJanuary 20, 2025 | globenewswire.comA tiny 1% move could have you targeting triple-digit gains with Gamma PocketsWhat if you knew exactly how to spot certain stocks Wall Street could be forced to buy… and you had a special trading setup for steering their moves into an opportunity? I bet you’d find that thrilling! Well, thanks to an unusual anomaly in the options markets, regular traders like me and you can do exactly that with the ‘Gamma Pockets’ You see, spotting these Gamma Pockets has changed the entire way I look at the market because we can now target wins like this in just 5 days or less…January 31, 2025 | WealthPress (Ad)Nyxoah SA Ordinary SharesJanuary 9, 2025 | morningstar.comNyxoah: The Future Of OSADecember 30, 2024 | seekingalpha.comPublication relating to transparency notificationsDecember 20, 2024 | globenewswire.comSee More Nyxoah Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Nyxoah? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nyxoah and other key companies, straight to your email. Email Address About NyxoahNyxoah (NASDAQ:NYXH), a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.View Nyxoah ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? Upcoming Earnings PayPal (2/3/2025)Palantir Technologies (2/3/2025)NXP Semiconductors (2/3/2025)Mitsubishi UFJ Financial Group (2/3/2025)Mondelez International (2/4/2025)Advanced Micro Devices (2/4/2025)Alphabet (2/4/2025)Alphabet (2/4/2025)Amgen (2/4/2025)Banco Bilbao Vizcaya Argentaria (2/4/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
